Stemital
The computed 12-month bankruptcy probability of Stemital is 2.5% (average). The 2024 annual accounts show equity of €74k and a net result of €-10k. Equity is growing by ~13.3% per year across the filed fiscal years. The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €74k |
| Net result | €-10k |
| Active | 4 yrs |
| Locations | 1 |
Strong profile, led by stability.
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit from Starter.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil–Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Fiscal year | 2024 |
|---|---|
| Revenue | — |
| EBITDA | €889 |
| Net profit | €-10k |
| Cash flow | €472 |
| Staff costs | — |
| Income taxes | — |
| Dividends | — |
| Total assets | €127k |
| Equity | €74k |
| Debt | €53k |
| of which ≤ 1y | €53k |
| of which > 1y | — |
| Working capital | €29k |
| Employees (FTE) | — |
| 2024 | |
|---|---|
| Current ratio | 1.54 |
| Quick ratio | 1.04 |
| Working capital ratio | 22.4% |
| Solvency | 58.5% |
| Debt / equity | 0.71 |
| Long-term debt ratio | — |
| Interest coverage | 1.74 |
| Gross margin | — |
| Net margin | — |
| ROA | -8.2% |
| ROE | -14.0% |
| EBITDA margin | — |
| Days sales outstanding | — |
| Days payable outstanding | — |
| Inventory turnover | — |
| Days inventory (DSI) | — |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet — Assets | ||
| TOTAL ASSETS | 20/58 | €127k |
| Fixed assets | 21/28 | €46k |
| Intangible fixed assets | 21 | €399 |
| Tangible fixed assets | 22/27 | €45k |
| Current assets | 29/58 | €81k |
| Stocks & contracts in progress | 3 | €27k |
| Amounts receivable within one year | 40/41 | €22k |
| Cash & bank | 54/58 | €32k |
| Balance sheet — Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €127k |
| Equity | 10/15 | €74k |
| Contributions / capital | 10/11 | €3k |
| Reserves | 13 | €82k |
| Accumulated profits (losses) | 14 | €-10k |
| Amounts payable | 17/49 | €53k |
| Amounts payable within one year | 42/48 | €53k |
| Trade debts payable within one year | 44 | €8k |
| Income statement | ||
| Gross operating margin | 9900 | €2k |
| Operating result | 9901 | €-10k |
| Financial income | 75 | €92 |
| Financial charges | 65 | €510 |
| Result before taxes | 9903 | €-10k |
| Net result for the period | 9904 | €-10k |
| Result to be appropriated | 9905 | €-10k |
| NACE primary | 25401 |
| Legal form | Private limited company(610) |
| Incorporation | 23-12-2021 |
| Status | Active |
| Postal code | 2300 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates — not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13452N1289/00K000 | Flanders | 941 m² | 1 · 147 m² | 8.0 m |
A single timeline of everything that happened to this company — publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | Stemital |